Clinical Supply Distribution Strategy – Planning & Adapting

Source: PCI Pharma Services
Map global Logistics GettyImages-1202209630

Neil Fox, PCI’s Clinical Supply Manager, recently discussed how to effectively plan your distribution strategy and the importance of early planning. In this article, he covers how to ensure your distribution plan is robust and the information needed to plan your distribution strategy, how to best determine your depot requirements, how to efficiently adapt to study changes, as well as how COVID may impact your distribution planning.

Neil Fox has 9 years’ experience in the pharmaceutical industry working in clinical diagnostics, veterinary pharmaceuticals and for the past 7 years, clinical trial supply. In his current role, Neil forms part of the PCI SMART team and responsible for supporting clients in the design, management and oversight of their clinical trial supply chain across a range of study phases and therapeutic areas.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online